-
1
المؤلفون: Daniela Gaglio 1, 2, Marcella Bonanomi 2, 3, Silvia Valtorta 1, 4, Rohit Bharat 23, Marilena Ripamonti 1, Federica Conte 2, 5, Giulia Fiscon 2, Nicole Righi 2, Elisabetta Napodano 1, Federico Papa 2, Isabella Raccagni 1, 6, Seth J Parker 7, 8, Ingrid Cifola 9, Tania Camboni 9, Paola Paci 2, Anna Maria Colangelo 2, Marco Vanoni 2, Christian M Metallo 7, Rosa Maria Moresco 1, Lilia Alberghina 2
المساهمون: Gaglio., D, Bonanomi, M, Valtorta, S, Bharat, R, Ripamonti, M, Conte, F, Fiscon, G, Righi, N, Napodano, E, Papa, F, Raccagni, I, J Parker, S, Cifola, I, Camboni, T, Paci, P, Colangelo, A, Vanoni, M, M Metallo, C, Moresco, R, Alberghina, L
المصدر: Cancer & Metabolism, Vol 8, Iss 1, Pp 1-15 (2020)
Cancer & metabolism 8 (2020): 22. doi:10.1186/s40170-020-00227-4
info:cnr-pdr/source/autori:Daniela Gaglio 1,2, Marcella Bonanomi 2,3, Silvia Valtorta 1,2,4, Rohit Bharat 23, Marilena Ripamonti 1,2, Federica Conte 2,5, Giulia Fiscon 2,5, Nicole Righi 2,3, Elisabetta Napodano 1,2, Federico Papa 2,5, Isabella Raccagni 1,2,6, Seth J Parker 7,8, Ingrid Cifola 9, Tania Camboni 9, Paola Paci 2,5,10, Anna Maria Colangelo 2,3, Marco Vanoni 2,3, Christian M Metallo 7,8, Rosa Maria Moresco 1,2,4, Lilia Alberghina 2,3/titolo:Disruption of redox homeostasis for combinatorial drug efficacy in K-Ras tumors as revealed by metabolic connectivity profiling/doi:10.1186%2Fs40170-020-00227-4/rivista:Cancer & metabolism/anno:2020/pagina_da:22/pagina_a:/intervallo_pagine:22/volume:8
Cancer & Metabolismمصطلحات موضوعية: Glutamine, Metabolic rewiring, metabolic cancer therapy, metabolic signature, glycolysis, glutamine, combinatorial drugs treatment, precision oncology, metabolic connectivity, Metabolic cancer therapy, lcsh:RC254-282, Nucleic acid metabolism, chemistry.chemical_compound, Metabolic connectivity, Metabolomics, Metabolic signature, Combinatorial drug treatment, Glycolysis, Metabolic rewiring, Precision oncology, Cancer Metabolism, Chemistry, Cell growth, Glutaminase, Research, Metabolism, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cell biology, Psychiatry and Mental health, Metabolic pathway, Cancer cell, Growth inhibition
-
2
المؤلفون: Silvia Valtorta 1, 2, 3, 4, Alessia Lo Dico 5, Isabella Raccagni 1, Daniela Gaglio 2, Sara Belloli 2, Letterio S. Politi 6, 7, 8, Cristina Martelli 5, Cecilia Diceglie 5, 1, Marcella Bonanomi 4, Giulia Ercoli 9, Valentina Vaira 5, 9, Luisa Ottobrini 2, 5, Rosa Maria Moresco 1
المصدر: Oncotarget (2017).
info:cnr-pdr/source/autori:Silvia Valtorta 1,2,3,4,*, Alessia Lo Dico 5,*, Isabella Raccagni 1,2,3,4, Daniela Gaglio 2,4, Sara Belloli 2,3,4, Letterio S. Politi 6,7,8, Cristina Martelli 5, Cecilia Diceglie 5,1, Marcella Bonanomi 4, Giulia Ercoli 9, Valentina Vaira 5,9, Luisa Ottobrini 2,5,* and Rosa Maria Moresco 1,2,3,4,*/titolo:Metformin and Temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models/doi:/rivista:Oncotarget/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volumeمصطلحات موضوعية: glioblastoma multiforme, metformin, temozolomide, glioma stem cells, metabolism